# Aurobindo Pharma Limited – FDA Inspection, Sep 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/9cf54b3a-8e21-4051-b7ac-26a4ad57dcff
Source feed: FDA_Inspections

> FDA inspection 684549 of Aurobindo Pharma Limited, September 17, 2010. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 684549
- Company Name: Aurobindo Pharma Limited
- Inspection Date: 2010-09-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1286862 - 2025-09-05](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/bad39678-8eb7-42c7-b820-7b3bab50ca4f)
- FDA Inspection 1241780 - 2023-03-09
- FDA Inspection 1118385 - 2020-02-21
- [FDA Inspection 1046218 - 2018-03-16](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/d4cc3587-20be-4443-8712-6e49c304278b)
- FDA Inspection 847151 - 2013-08-16

Company: https://www.keypedia.com/companies/aurobindo-pharma-limited/9bedb5d4-0483-4173-bc76-1c5737a28fc1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c